VINDESINE AND ICRF-159 COMBINATION CHEMOTHERAPY

被引：0
|
作者：
STEVENS, EE [1 ]
EINHORN, LH [1 ]
ROHN, RJ [1 ]
机构：
[1] INDIANA UNIV,MED CTR,INDIANAPOLIS,IN 46223
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1980年 / 21卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：135 / 135
页数：1
相关论文
共 50 条
  • [41] ICRF-159 INDUCED ENHANCEMENT OF RADIATION RESPONSE IN COMBINED MODALITY THERAPIES
    KOVACS, CJ
    EVANS, MJ
    BURHOLT, DR
    SCHENKEN, LL
    RADIATION RESEARCH, 1978, 74 (03) : 580 - 580
  • [42] ENHANCEMENT OF EXPERIMENTAL LUNG METASTASES BY MELANOMA CELLS TREATED WITH ICRF-159
    LAZO, JS
    INGBER, DE
    SARTORELLI, AC
    FEDERATION PROCEEDINGS, 1978, 37 (03) : 316 - 316
  • [43] ADJUVANT ORAL RAZOXANE (ICRF-159) IN RESECTABLE COLORECTAL-CANCER
    GILBERT, JM
    HELLMANN, K
    EVANS, M
    CASSELL, PG
    STOODLEY, B
    ELLIS, H
    WASTELL, C
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 8 (03) : 293 - 299
  • [44] PHASE-2 STUDY OF ICRF-159 IN PATIENTS WITH METASTATIC COLORECTAL CARCINOMA PREVIOUSLY EXPOSED TO SYSTEMIC CHEMOTHERAPY
    BELLET, RE
    ENGSTROM, PF
    CATALANO, RB
    CREECH, RH
    MASTRANGELO, MJ
    CANCER TREATMENT REPORTS, 1976, 60 (09): : 1395 - 1397
  • [45] A TRIAL OF RAZOXANE (ICRF-159) IN PATIENTS WITH PRIOR THERAPY FOR HODGKINS LYMPHOMA
    CORDER, MP
    MCFADDEN, DB
    BELL, SJ
    CANCER, 1984, 54 (08) : 1496 - 1498
  • [46] RADIOTHERAPY PLUS ICRF-159 FOR ADVANCED LIMITED EXTENT CARCINOMA OF THE LUNG
    CORDER, MP
    TEWFIK, HH
    CLAMON, GH
    PANTHER, SK
    HERBST, KD
    LEIMERT, JT
    BYFIELD, JE
    CLINICAL RESEARCH, 1980, 28 (02): : A412 - A412
  • [47] ADJUVANT ORAL RAZOXANE (ICRF-159) IN RESECTABLE COLO-RECTAL CANCER
    SLEVIN, ML
    HARVEY, VJ
    WRIGLEY, PFM
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1983, 10 (03) : 228 - 228
  • [48] EFFECT OF STEREOISOMERS RELATED TO ICRF-159 ON METASTASIS OF B-16 MELANOMA
    ZWILLING, BS
    CAMPOLITO, LB
    REICHES, NA
    GEORGE, T
    WITIAK, DT
    BRITISH JOURNAL OF CANCER, 1981, 44 (04) : 578 - 583
  • [49] PHASE-2 EVALUATION OF ICRF-159 (NSC-129943) IN LYMPHOMAS
    FLANNERY, EP
    CORDER, MP
    PAJAK, TF
    SHEEHAN, WW
    BATEMAN, JR
    CLINICAL RESEARCH, 1975, 23 (04): : A527 - A527
  • [50] MITIGATING EFFECTS OF ICRF-159 (RAZOXANE) ON A DAUNOMYCIN-INDUCED CARDIOMYOPATHY IN MICE
    FISCHER, VW
    LAROSE, LS
    WANG, GM
    DRUG AND CHEMICAL TOXICOLOGY, 1982, 5 (02) : 155 - 164
12345